New pill tested for severe skin rash relief
NCT ID NCT07370909
Summary
This study is testing whether an oral tablet called LW402 can safely reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. About 480 participants will take either the active tablet or a placebo pill for 16 weeks to see which group experiences greater skin improvement. The goal is to control the skin disease and reduce symptoms, not to provide a permanent cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, China
Contact
Conditions
Explore the condition pages connected to this study.